Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Exclusive manufacturer-reported metrics
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

FDA Approves Aerie’s Rocklatan for Open-Angle Glaucoma, Ocular Hypertension

The US FDA has approved Aerie Pharmaceuticals’ Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or o...

EyePoint Launches DEXYCU in the US for Postoperative Inflammation

EyePoint Pharmaceuticals announced March 12 that is has launched DEXYCU in the US for intraocular treatment of postoperative inflammation. DEXYCU (dexamethasone intraocular suspension) 9% is admini...

Carl Zeiss Meditec Gains US Clearance for CIRRUS HD-OCT Enhancement

Carl Zeiss Meditec announced March 7 that it has received US FDA 510(k) clearance for new software for its CIRRUS HD-OCT platform that adds epithelial thickness mapping capability to its Anterior S...

US Orders Guardian to Stop Compounding Drugs

The US FDA announced March 13 that a federal court has stopped Guardian Pharmacy Services of Dallas from compounding drugs. The government alleges that Guardian has been manufacturing drugs that ar...

Genentech-backed Study Found AI Can Detect DME Severity from Color Fundus Photos

Artificial Intelligence (AI) can detect the severity of diabetic macular edema (DME) through analysis of color fundus photographs, a Genentech-backed study found. Genentech said the study suggests ...

Harrow Health Reports 2018 Revenues of $41.4 Million

Harrow Health, formerly Imprimis Pharmaceuticals, announced March 12 that its total revenues for 2018 were $41.4 million, a 55 percent increase over the 2017 total of $26.8 million. The San Diego c...

Eurazeo Acquires DORC from Montagu for $339 Million

Paris-based Eurazeo Capital has agreed to acquire Dutch Ophthalmic Research Center (DORC) from Montagu Private Equity, of London, for $339 million (nearly €300 million), the companies announced Mar...

Q BioMed Licenses Biomarker for Glaucoma from Washington University

Q BioMed has agreed to exclusively license a biomarker for glaucoma from Washington University in St. Louis, the New York-based company announced March 11. The biomarker, growth differentiation fac...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

US Surveys
May select more than one
Outside of US Surveys

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2019 Market Scope, LLC. All Rights reserved.